Magnetic resonance imaging for axillary staging in patients with breast cancer

Journal of Magnetic Resonance Imaging

Volumn 30, Issue 2, 2009, Pages 309-312

  Mortellaro, Vincent E ^a   Marshall, Julia ^b   Singer, Lauren ^a   Hochwald, Steven N ^a   Chang, Myron ^a   Copeland, Edward M ^a   Grobmyer, Stephen R ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Cancer staging; Hilum; Lymph nodes; MRI

Indexed keywords

FAT;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE RECONSTRUCTION; IMAGE SUBTRACTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SIGNAL DETECTION; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 68049145125     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21802     Document Type: Article

References (19)

1. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75-89. (Pubitemid 46535708)
2. Tilanus-Linthorst MM, Obdeijn AI, Bontenbal M, Oudkerk M. MRI in patients with axillary metastases of occult breast carcinoma. Breast Cancer Res Treat 1997;44:179-182. (Pubitemid 27248466)
3. Henry-Tillman RS, Harms SE, Westbrook KC, Korourian S, Klimberg VS. Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. Am J Surg 1999;178:496-500. (Pubitemid 30058299)
4. Mortellaro VE, Marshall J, Harms SE, Hochwald SN, Copeland EM, Grobmyer SR. Breast MR for the evaluation of occult nipple discharge. Am Surg 2008;74:739-742.
5. Grobmyer SR, Mortellaro VE, Marshall J, et al. Is there a role for routine use of MRI in the selection of patients for breast conserving cancer surgery? J Am Coll Surg 2008;5:1045-1050.
6. Liberman L, Mason G, Morris EA, Dershaw DD. Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR Am J Roentgenol 2006;186:426-430. (Pubitemid 46100312)
7. Clayton F, Hopkins CL. Pathologic correlates of prognosis in lymph node-positive breast carcinomas. Cancer 1993;71:1780-1790. (Pubitemid 23067394)
8. Masood S. Prognostic/predictive factors in breast cancer. Clin Lab Med 2005;25:809-825.
9. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-398; discussion 398-401.
10. Ueda S, Tsuda H, Asakawa H, et al. Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer. BMC Cancer 2008;8:165. (Pubitemid 351877805)
11. Fuster D, Duch J, Paredes P, et al. Preoperative staging of large primary breast cancer with [18F] fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. J Clin Oncol 2008;26:29.
12. Kvistad KA, Rydland J, Smethurst HB, et al. Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI. Eur Radiol 2000;10:1464-1471. (Pubitemid 30683071)
13. Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 1997;169:417-424. (Pubitemid 27334851)
14. Murray AD, Staff RT, Redpath TW, et al. Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes. Br J Radiol 2002;75:220-228.
15. Hsiang DJ, Yamamoto M, Mehta RS, et al. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. Arch Surg 2007;142:855-861; discussion 860-861. (Pubitemid 47437303)
16. Szabó BK, Aspelin P, Kristoffersen Wiberg M, Tot T, Boné B. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 2003;13:2425-2435. (Pubitemid 37407473)
17. Memarsadeghi M, Riedl CC, Kaneider A, et al. Axillary lymph node metastases in patients with breast carcinomas: assessment with non-enhanced versus uspio-enhanced MR imaging. Radiology 2006;241:367-377. (Pubitemid 44632881)
18. Cuenca AG, Jiang H, Hochwald SN, Delano M, Cance WG, Grobmyer SR. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 2006;107:459-466. (Pubitemid 44107204)
19. Sharma P, Brown S, Bengtsson N, et al. Gold speckled multimodal nanoparticles for non-invasive bioimaging. Chem Mater 2008;20: 6087-6094.